Stefan Münch

I am a partner in our Corporate and M&A team in Munich and a member of our Tech & Comms and Life Sciences & Healthcare Sector Groups, offering our clients in-depth experience in all facets of corporate law (transactional and non-transactional), alongside a deep understanding of their sector and business. Beside my legal advice, I am a member of the management of the German offices.

My specialisms are:

M&A,
PE & VC,
Joint ventures,
Reorganisations,
Employee incentive plans,
Global corporate housekeeping Projects and
General corporate law.

Over the years, I have gained broad experience in advising purchasers and sellers in German and international M&A as well as investors and funds in venture capital investments and financing rounds. This includes drafting and negotiating term sheets, share/asset purchase agreements, investment and shareholder agreements, joint venture and merger agreements and the coordination and undertaking of due diligence procedures.

I also advise our clients on questions concerning the reorganisation and restructuring of companies with particular focus on corporate and insolvency law and corporate governance.

My client base includes names of leading global innovation-strong companies from various industries, such as technology businesses Broadsoft, FLIR Systems, Luxoft or TomTom or companies active in life sciences and healthcare such as Precision Medicine, Omnicell or Tilray.

I have previously spent time working in the US and have been increasingly advising US clients in recent years. I am also a member of our China Desk Germany and regularly act on outbound China transactions. Years of working with US and China have proved extremely effective at perfecting my project management skills, so indispensable on complex cross-border transactions in these cost-conscious times.

I am co-author of the handbook 'Steueroptimierter Unternehmenskauf' (Tax-optimised Business Acquisition) published by Gabler Verlag.

• US secondment at one of our partner law firms in San Francisco
• Elgato Systems: Advised on the sale of the Elgato Gaming business to US gaming accessory specialist CORSAIR, a world leader in high-performance PC peripherals and components.
• Luxoft Holding (NYSE-listed international IT-provider): Advised on the acquisition of provider of software development services and IP-based solutions Objective Software GmbH and its Italian subsidiary.
• Omnicell (NASDAQ-listed): Transaction advice throughout Europe, for example in connection with the acquisition of Mach4 Automatisierungstechnik GmbH and further foreign acquisitions.
• Precision Medicine Group (specialist scientific services company supporting life science companies in the development of medical devices): Advised on the acquisition of all the shares in Epiontis GmbH, a leading provider of immunological monitoring services that uses epigenetics, and further foreign acquisitions.
• TomTom: Advised in connection with the acquisition of Autonomos GmbH, a technology start-up from Berlin which provided R&D consultancy services in relation to various autonomous driving projects.
• Unchained Labs (US life sciences company): Advised on the acquisition of the German company rap.ID Particle Systems GmbH.